Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

166
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
166
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

909
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
909
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

338
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
338
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

112
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
112
Three-Compartment Open Model01:06

Three-Compartment Open Model

345
The three-compartment open model is a pharmacokinetic model used to describe the distribution and elimination of drugs following extravascular administration. It comprises a central compartment representing the plasma and two peripheral compartments. The highly perfused peripheral compartment represents organs and tissues with a rich blood supply, such as the liver, kidneys, and lungs. The scarcely perfused peripheral compartment represents tissues with lower blood supply, such as adipose...
345
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

93
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
93

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploratory analysis of pharmacist involvement in motivational interviewing intervention for patients with prescription opioid misuse behaviors.

JAPhA practice innovations·2026
Same author

Silos to synergy: Developing collaborative scholarship theme teams for pharmacy faculty.

Currents in pharmacy teaching & learning·2026
Same author

A short communication of pain outcomes following a pharmacist-delivered alcohol and opioid use reduction intervention.

Drug and alcohol dependence reports·2026
Same author

A community pharmacy vaccination nudge intervention: Final results of a nationwide study.

Research in social & administrative pharmacy : RSAP·2025
Same author

A longitudinal self-reflection training activity grounded in growth mindset theory for pharmacy residents.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2025
Same author

From implementation to impact: Evaluation of a Pharmacist Primary Care Certificate Training Program using the RE-AIM framework.

Journal of the American Pharmacists Association : JAPhA·2025

Related Experiment Video

Updated: Aug 16, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.7K

Exploring the Membership Pharmacy Model: Initial impact and feasibility.

Kenneth C Hohmeier, Phil Baker, Cortney Storey

    Journal of the American Pharmacists Association : Japha
    |December 23, 2022
    PubMed
    Summary
    This summary is machine-generated.

    A novel Membership Pharmacy Model offers a viable alternative to traditional payment systems, improving medication adherence and providing significant cost savings for employers. This value-based approach benefits patients, pharmacies, and employers.

    More Related Videos

    Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
    11:06

    Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

    Published on: April 7, 2023

    2.1K
    An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
    09:41

    An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

    Published on: July 15, 2015

    8.7K

    Related Experiment Videos

    Last Updated: Aug 16, 2025

    Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
    05:10

    Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

    Published on: December 11, 2016

    9.7K
    Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
    11:06

    Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

    Published on: April 7, 2023

    2.1K
    An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
    09:41

    An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

    Published on: July 15, 2015

    8.7K

    Area of Science:

    • Pharmacy Practice
    • Health Economics
    • Value-Based Care

    Background:

    • Traditional pharmacy payment models present misaligned incentives and a lack of transparency in prescription costs.
    • The evolving role of community pharmacists necessitates a shift towards more effective reimbursement strategies.
    • Existing fee-for-service models do not adequately support improved patient outcomes.

    Purpose of the Study:

    • To develop a payment strategy for a Membership Pharmacy Model in an independent community pharmacy.
    • To explore the impact of a novel value-based pharmacy payment model on patients, pharmacies, and self-insured employers.

    Main Methods:

    • A pilot program was implemented at Good Shepherd Pharmacy, a nonprofit Membership Pharmacy.
    • The study utilized a recurring revenue model, bypassing pharmacy benefit managers.
    • The RE-AIM framework was employed to assess the pilot program's outcomes.

    Main Results:

    • The pilot enrolled 34 patients, filling 1399 prescriptions over 13 cycles.
    • Proportion of days covered for diabetes and cholesterol medications increased significantly.
    • Employers realized net savings of $67,843 (35% reduction in pharmacy spending).
    • Pharmacy revenue was generated through synchronization fees, totaling $41,970.

    Conclusions:

    • The Membership Pharmacy Model offers a potentially viable alternative to traditional fee-for-service and buy-and-bill models.
    • This model leverages actual acquisition costs, lean operations, and value-based reimbursement.
    • The findings suggest a shift towards more transparent and patient-centered pharmacy payment structures is feasible.